Sevoflurane vs Propofol Anesthesia in Obese Patients Undergoing Lumbar Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAtaturk University

About this trial

This randomized, single-center, single-masked clinical trial aims to compare the immunomodulatory effects of sevoflurane-based inhalational anesthesia and propofol-based total intravenous anesthesia in obese patients undergoing elective lumbar instrumentation surgery. Seventy patients will be randomized into two groups: a propofol group and a sevoflurane group. Blood samples will be collected preoperatively, at postoperative 6 hours, and at postoperative 24 hours. Pentraxin-3 and serum amyloid A levels will be evaluated as primary inflammatory biomarkers together with IL-6, TNF-α, CRP, glucose, and complete blood count parameters.

Eligibility criteria

Qualifiers

Patients aged between 18 and 65 years

Patients scheduled for elective lumbar instrumentation surgery

Body mass index between 30 and 34.9 kg/m²

Patients who provided written informed consent

Disqualifiers

Known allergy to inhalational or intravenous anesthetic agents

Acute or chronic infectious disease

Autoimmune disease or immunodeficiency

Surgery within the last 3 months

Trial design

Treatments tested in this trial

  • Propofol (Astra-Zeneca)
  • Sevoflurane

Treatment groups

70 Participants
are divided into 2 treatment groups

Sponsors and collaborators